Through single-cell analysis, we have uncovered a connection between breast cancer cells and PD-1-expressing CD8 cells, further elucidating the mechanisms underlying the heightened sensitivity of high-risk breast cancer patients to PD-1 therapy (Figure 7E). The gene discussed is CD8A; the disease is breast carcinoma.